These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18179388)

  • 41. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
    Epp T; Waldner C; Townsend HG
    Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype.
    Galel SA; Webster J; Roa L
    Transfusion; 2008 Jul; 48(7):1486-94. PubMed ID: 18466179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection.
    Danial-Farran N; Eghbaria S; Schwartz N; Kra-Oz Z; Bisharat N
    Epidemiol Infect; 2015 Mar; 143(4):857-63. PubMed ID: 24865988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. West Nile virus activity--United States, September 15-21, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(37):875-6. PubMed ID: 15385920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in seroprevalence of West Nile virus across Illinois in free-ranging birds from 2001 through 2004.
    Beveroth TA; Ward MP; Lampman RL; Ringia AM; Novak RJ
    Am J Trop Med Hyg; 2006 Jan; 74(1):174-9. PubMed ID: 16407365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. West Nile virus activity--United States, September 29-October 5, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(39):922-3. PubMed ID: 15470326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The continuing spread of West Nile virus in the western hemisphere.
    Gubler DJ
    Clin Infect Dis; 2007 Oct; 45(8):1039-46. PubMed ID: 17879923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [West Nile viral meningo-encephalitis in Tunisia].
    Triki H; Murri S; Le Guenno B; Bahri O; Hili K; Sidhom M; Dellagi K
    Med Trop (Mars); 2001; 61(6):487-90. PubMed ID: 11980397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. West Nile encephalitis outbreak in Kerala, India, 2011.
    Anukumar B; Sapkal GN; Tandale BV; Balasubramanian R; Gangale D
    J Clin Virol; 2014 Sep; 61(1):152-5. PubMed ID: 24985196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. West Nile virus activity--United States, September 22-28, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(38):900. PubMed ID: 15457147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.
    Yakub I; Lillibridge KM; Moran A; Gonzalez OY; Belmont J; Gibbs RA; Tweardy DJ
    J Infect Dis; 2005 Nov; 192(10):1741-8. PubMed ID: 16235172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. West Nile virus: the complex biology of an emerging pathogen.
    Ulbert S
    Intervirology; 2011; 54(4):171-84. PubMed ID: 21576931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. West Nile virus and non-West Nile virus mortality and coinfection of American crows (Corvus brachyrhynchos) in California.
    Wheeler SS; Woods LW; Boyce WM; Eckstrand CD; Langevin SA; Reisen WK; Townsend AK
    Avian Dis; 2014 Jun; 58(2):255-61. PubMed ID: 25055630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. West Nile virus infection in the pediatric population.
    Civen R; Villacorte F; Robles DT; Dassey DE; Croker C; Borenstein L; Harvey SM; Mascola L
    Pediatr Infect Dis J; 2006 Jan; 25(1):75-8. PubMed ID: 16395109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mental status after West Nile virus infection.
    Haaland KY; Sadek J; Pergam S; Echevarria LA; Davis LE; Goade D; Harnar J; Nofchissey RA; Sewel CM; Ettestad P
    Emerg Infect Dis; 2006 Aug; 12(8):1260-2. PubMed ID: 16965710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic variants and susceptibility to neurological complications following West Nile virus infection.
    Loeb M; Eskandarian S; Rupp M; Fishman N; Gasink L; Patterson J; Bramson J; Hudson TJ; Lemire M
    J Infect Dis; 2011 Oct; 204(7):1031-7. PubMed ID: 21881118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemokine control of West Nile virus infection.
    Lim JK; Murphy PM
    Exp Cell Res; 2011 Mar; 317(5):569-74. PubMed ID: 21376172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection.
    Cook RL; Xu X; Yablonsky EJ; Sakata N; Tripp JH; Hess R; Piazza P; Rinaldo CR
    Am J Trop Med Hyg; 2010 Nov; 83(5):1133-6. PubMed ID: 21036852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.
    Lim JK; McDermott DH; Lisco A; Foster GA; Krysztof D; Follmann D; Stramer SL; Murphy PM
    J Infect Dis; 2010 Jan; 201(2):178-85. PubMed ID: 20025530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of CCR5Δ32 on the risk of infection, Staphylococcus aureus carriage, and plasma concentrations of chemokines in Danish blood donors.
    Dinh KM; Kaspersen KA; Mikkelsen S; Kjerulff BD; Boldsen JK; Petersen MS; Burgdorf KS; Sørensen E; Aagaard B; Forman-Ankjær B; Bruun MT; Banasik K; Hansen TF; Nyegaard M; Rohde PD; Brunak S; Hjalgrim H; Ostrowski SR; Pedersen OB; Ullum H; Erikstrup LT; Erikstrup C
    EBioMedicine; 2024 Nov; 109():105406. PubMed ID: 39437658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.